Boston Scientific has begun testing its Vercise deep-brain stimulator on U.S. Parkinson's patients after receiving good interim results in a European study. More
-
Sponsored By:
-
Sponsored By:
-
Sponsored By:
Medical Stocks
Recent Articles
Trade of the Day: Boston Scientific (BSX)
I'm returning to a name we've featured on the Trade of the Day before to take advantage of this renewed bullish trend--and the fact that it has options under a dollar makes the deal even sweeter. More
2 Stocks to Buy, 2 to Sell in Medical Appliances
The medical appliance industry has been hot in 2013, but not every stock is worth hanging onto anymore. Here's a look at two buys and two sells in the sector. More
Trade of the Day: Boston Scientific (BSX)
We are seeing top line growth, margin growth, and earnings growth all at the same time in this medical device stock--a winning trifecta for a turnaround story. More
Flu’s Pain Is All Gain for These Companies
As this year's flu season intensifies, so do the profits for some businesses such as vaccine makers, pharmacies and even certain food and beverage makers. More
OPKO Health’s Healthy Buyout Binge
This healthcare name is rapidly building up a business worth watching. And the possibility of OPKO itself getting bought out isn't too remote. More
J&J Knew About Hip Implant Problems
Documents unsealed by a California court indicate that Johnson & Johnson knew about defective hip implants two years before it recalled them. More
